Omada Health CEO exercises options, sells shares

Omada Health, Inc. CEO Sean P. Duffy exercised stock options for 12,944 shares of common stock at $5.82 per share and on the same day sold 12,944 shares at a weighted average price of $20.3961 in open-market transactions between $20.15 and $20.58.

Rhea-AI Filing Summary

Omada Health, Inc. CEO Sean P. Duffy exercised stock options for 12,944 shares of common stock at $5.82 per share and on the same day sold 12,944 shares at a weighted average price of $20.3961 in open-market transactions between $20.15 and $20.58. The sale was executed under a Rule 10b5-1 trading plan adopted March 13, 2026. After the exercise, he held 142,483 options and 851,659 common shares indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary 10b5-1

Exercise and Sale: 12,944 shares ($189K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Duffy Sean P.

Role Chief Executive Officer

Sold 12,944 shs ($264K)

Approx. gross sale proceeds $264K

Approx. exercise cost $75K

Approx. pre-tax spread $189K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F4	12,944	$0.00	$0.00
Exercise	Common Stock	12,944	$5.82	$75K
Sale	Common Stock F1, F2	12,944	$20.3961	$264K
holding	Common Stock F3	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 142,483 contracts (Direct); Common Stock — 411,861 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)

Footnotes (4)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $20.15 to $20.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. F3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
4. F4. 100% of the shares subject to the option are fully vested and exercisable.

Key Figures

Shares sold: 12,944 shares Sale price (weighted average): $20.3961 per share Options exercised: 12,944 shares at $5.82 +3 more

6 metrics

Shares sold 12,944 shares Common stock sold on 2026-08-03 in open-market transactions under a Rule 10b5-1 plan

Sale price (weighted average) $20.3961 per share Weighted average sale price, with individual trades ranging from $20.15 to $20.58

Options exercised 12,944 shares at $5.82 Stock options exercised at $5.82 per share on 2026-08-03 to acquire common stock

Options remaining 142,483 options Stock options remaining after exercising 12,944-option portion of an already fully vested grant

Indirect common shares 851,659 shares Common stock held indirectly in family trusts, with beneficial ownership disclaimed except for pecuniary interest

Option expiration 2029-08-21 Expiration date of the stock option from which 12,944 shares were exercised

Key Terms

Rule 10b5-1 trading plan, weighted average price, pecuniary interest, Stock Option (Right to Buy), +1 more

5 terms

Rule 10b5-1 trading plan financial

"Transaction made pursuant to a 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported above reflects the weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

pecuniary interest financial

"disclaims beneficial ownership except to the extent of his pecuniary interest"

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy) reported as derivative"

indirect ownership financial

"Common Stock entry marked indirect, held in family trusts"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) CEO Sean P. Duffy report in this Form 4?

Sean P. Duffy reported an exercise-and-sell transaction involving 12,944 Omada Health shares. He exercised stock options at $5.82 per share to acquire 12,944 common shares, then sold the same number at a $20.3961 weighted average price in open-market trades.

How many Omada Health (OMDA) shares did Sean P. Duffy sell, and at what prices?

He sold 12,944 shares of Omada Health common stock at a weighted average price of $20.3961 per share. The sale was executed in multiple trades, with individual prices ranging from $20.15 to $20.58, as disclosed in the pricing footnote.

What stock options did Sean P. Duffy exercise in Omada Health (OMDA)?

He exercised options covering 12,944 shares of Omada Health common stock at an exercise price of $5.82 per share. The underlying option was fully vested and exercisable, with an expiration date of August 21, 2029, before he completed the reported sale.

What Omada Health (OMDA) holdings does Sean P. Duffy report after these transactions?

After the transactions, he reported holding 142,483 stock options directly and 851,659 common shares indirectly through family trusts. He disclaims beneficial ownership of the trust-held shares except to the extent of his pecuniary interest, reflecting limited economic attribution to him personally.

Were Sean P. Duffy’s Omada Health (OMDA) trades made under a Rule 10b5-1 plan?

Yes. The reported sale of 12,944 shares was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. The filing also checks the Rule 10b5-1 box, indicating the transactions were executed according to a pre-arranged trading plan rather than discretionary timing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 05:00 PM Accepted by SEC EDGAR 08/05/2026 - 04:59 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy Sean P.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/03/2026		M		12,944	A	$5.82	424,805	D
Common Stock	08/03/2026		S(1)		12,944	D	$20.3961(2)	411,861	D
Common Stock								851,659	I	See footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$5.82	08/03/2026		M			12,944	(4)	08/21/2029	Common Stock	12,944	$0	142,483	D

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This transaction was executed in multiple trades at prices ranging from $20.15 to $20.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

4. 100% of the shares subject to the option are fully vested and exercisable.

	/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)